Policy, Ethics and Law

政策、道德和法律

• 批准号: 7671945
• 负责人: Robert Mullan Cook-Deegan
• 金额: $ 14.81万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-03-15 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7671945
• 关键词: Address; Ensure; Ethics; Infection; Intervention; Laws; Policies; Prevention; Public Health; Research; Research Personnel; Resources; Risk; Technology; Time; Universities; Vaccines; biodefense; clinical care; drug candidate; ethical legal social implication; improved; meetings; member

Research, clinical care, and public health interventions related to emerging infections and biodefense raise critically important ethical, legal, and social issues. The Policy, Ethics and Law (PEL) Core will examine such issues under the direction of a multi-disciplinary Coordinating Committee drawn from the participating universities, inviting input from other collaborating investigators and outside experts. This PEL core will address the following specific aims: 1. To identify and address issues that arise in conducting research on emerging infections and for biodefense 2. To assist the SERCEB steering committee in identifying and managing dual-use research (that can be foreseeably misused) 3. To identify and address issues encountered in developing promising vaccines, drug candidates, and technologies into prevention or treatment interventions for emerging infections and for biodefense; 4. aw. To serve as an educational and consultative resource to SERCEB To collaborate with other Regional Centers of Excellence in addressing issues of policy, ethics, and These aims will be met by advising the SERCEB steering committee, by commissioning analysis by core members and outside experts, by developing educational resources, and by engaging with policy discussions locally, nationally, and internationally.

与新发感染和生物防御相关的研究、临床护理和公共卫生干预措施提高了 至关重要的伦理、法律的和社会问题。政策，道德和法律（PEL）核心将审查 在一个多学科协调委员会的指导下， 大学，邀请其他合作研究人员和外部专家提供意见。 这一《消除贫穷法》核心将实现以下具体目标： 1.确定和解决在对新发感染进行研究时出现的问题， 生物防御 2.协助SERCEB指导委员会确定和管理双重用途研究（可 滥用） 3.确定和解决在开发有前途的疫苗、候选药物和 用于新感染和生物防御的预防或治疗干预技术; 4. AW. 作为SERCEB的教育和咨询资源 与其他区域卓越中心合作，解决政策、道德和 为实现这些目标，将向SERCEB指导委员会提供咨询意见， 成员和外部专家，通过开发教育资源， 在当地、国内和国际上进行讨论。